KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Illumina (ILMN) EBT (2016 - 2026)

Illumina filings provide 18 years of EBT readings, the most recent being $157.0 million for Q1 2026.

  • On a quarterly basis, EBT fell 13.74% to $157.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.1 billion, a 219.5% increase, with the full-year FY2025 number at $1.1 billion, up 192.11% from a year prior.
  • EBT hit $157.0 million in Q1 2026 for Illumina, down from $377.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $720.0 million in Q3 2024 to a low of -$5.1 billion in Q1 2023.
  • Median EBT over the past 5 years was -$78.0 million (2023), compared with a mean of -$609.1 million.
  • Biggest five-year swings in EBT: plummeted 2120.22% in 2024 and later soared 266.97% in 2025.
  • Illumina's EBT stood at -$3.7 billion in 2022, then soared by 95.45% to -$167.0 million in 2023, then skyrocketed by 211.98% to $187.0 million in 2024, then soared by 101.6% to $377.0 million in 2025, then plummeted by 58.36% to $157.0 million in 2026.
  • The last three reported values for EBT were $157.0 million (Q1 2026), $377.0 million (Q4 2025), and $220.0 million (Q3 2025) per Business Quant data.